ASA Fundamental Analysis - ATLANTIC SAPPHIRE ASA

Name: ATLANTIC SAPPHIRE ASA (ASA) Stock
Brand: ATLANTIC SAPPHIRE ASA
Rating: 3 (3 reviews)

Fundamental Rating

ASA gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 59 industry peers in the Food Products industry. Both the profitability and financial health of ASA have multiple concerns. ASA is not overvalued while it is showing excellent growth. This is an interesting combination.

Quickly go to:

1. Profitability

1.1 Basic Checks

ASA had negative earnings in the past year.

In the past year ASA has reported a negative cash flow from operations.

ASA had negative earnings in each of the past 5 years.

ASA had a negative operating cash flow in each of the past 5 years.

1.2 Ratios

Looking at the Return On Assets, with a value of -61.34%, ASA is doing worse than 93.22% of the companies in the same industry.

The Return On Equity of ASA (-91.95%) is worse than 88.14% of its industry peers.

		Industry Rank	Sector Rank
ROA	-61.34%
ROE	-91.95%
ROIC	N/A

ROA(3y)-39.47%

ROA(5y)-35.64%

ROE(3y)-50.56%

ROE(5y)-45.74%

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

ASA does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.

		Industry Rank	Sector Rank
OM	N/A
PM (TTM)	N/A
GM	N/A

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3YN/A

GM growth 5YN/A

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

ASA does not have a ROIC to compare to the WACC, probably because it is not profitable.

The number of shares outstanding for ASA has been increased compared to 1 year ago.

ASA has more shares outstanding than it did 5 years ago.

ASA has a worse debt/assets ratio than last year.

2.2 Solvency

ASA has an Altman-Z score of -4.20. This is a bad value and indicates that ASA is not financially healthy and even has some risk of bankruptcy.

The Altman-Z score of ASA (-4.20) is worse than 89.83% of its industry peers.

ASA has a Debt/Equity ratio of 0.40. This is a healthy value indicating a solid balance between debt and equity.

ASA's Debt to Equity ratio of 0.40 is fine compared to the rest of the industry. ASA outperforms 66.10% of its industry peers.

		Industry Rank	Sector Rank
Debt/Equity	0.4
Debt/FCF	N/A
Altman-Z	-4.2

ROIC/WACCN/A

WACC8.33%

2.3 Liquidity

ASA has a Current Ratio of 2.10. This indicates that ASA is financially healthy and has no problem in meeting its short term obligations.

The Current ratio of ASA (2.10) is better than 77.97% of its industry peers.

ASA has a Quick Ratio of 1.74. This is a normal value and indicates that ASA is financially healthy and should not expect problems in meeting its short term obligations.

Looking at the Quick ratio, with a value of 1.74, ASA belongs to the top of the industry, outperforming 83.05% of the companies in the same industry.

		Industry Rank	Sector Rank
Current Ratio	2.1
Quick Ratio	1.74

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 86.91% over the past year.

ASA shows a strong growth in Revenue. In the last year, the Revenue has grown by 93.60%.

Measured over the past years, ASA shows a very strong growth in Revenue. The Revenue has been growing by 32.73% on average per year.

EPS 1Y (TTM)86.91%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%93.19%

Revenue 1Y (TTM)93.6%

Revenue growth 3Y10.64%

Revenue growth 5Y32.73%

Sales Q2Q%92.44%

3.2 Future

The Earnings Per Share is expected to grow by 81.32% on average over the next years. This is a very strong growth

Based on estimates for the next years, ASA will show a very strong growth in Revenue. The Revenue will grow by 26.22% on average per year.

EPS Next Y116.3%

EPS Next 2Y81.32%

EPS Next 3YN/A

EPS Next 5YN/A

Revenue Next Year70.85%

Revenue Next 2Y66.11%

Revenue Next 3Y11.1%

Revenue Next 5Y26.22%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

ASA reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.

ASA is valuated cheaply with a Price/Forward Earnings ratio of 0.03.

Compared to the rest of the industry, the Price/Forward Earnings ratio of ASA indicates a rather cheap valuation: ASA is cheaper than 100.00% of the companies listed in the same industry.

When comparing the Price/Forward Earnings ratio of ASA to the average of the S&P500 Index (22.63), we can say ASA is valued rather cheaply.

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	0.03

4.2 Price Multiples

		Industry Rank	Sector Rank
P/FCF	N/A
EV/EBITDA	N/A

4.3 Compensation for Growth

ASA's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.

A more expensive valuation may be justified as ASA's earnings are expected to grow with 81.32% in the coming years.

PEG (NY)N/A

PEG (5Y)N/A

EPS Next 2Y81.32%

EPS Next 3YN/A

More info and screens

Show best valued peers

5. Dividend

5.1 Amount

No dividends for ASA!.

		Industry Rank	Sector Rank
Dividend Yield	N/A

More info and screens

Find the best dividend stocks

Show peers with best dividend

ATLANTIC SAPPHIRE ASA

OSL:ASA (10/29/2025, 7:00:00 PM)

7.41

-0.31 (-4.08%)

Chartmill FA Rating

GICS SectorConsumer Staples

GICS IndustryGroupFood, Beverage & Tobacco

GICS IndustryFood Products

Earnings (Last)08-21 2025-08-21

Earnings (Next)04-22 2026-04-22/amc

Inst Owners9.22%

Inst Owner ChangeN/A

Ins Owners0.02%

Ins Owner ChangeN/A

Market Cap265.65M

Revenue(TTM)33.17M

Net Income(TTM)-151362000

Analysts40

Price Target171.22 (2210.66%)

Short Float %N/A

Short RatioN/A

Dividend

		Industry Rank	Sector Rank
Dividend Yield	N/A

Yearly DividendN/A

Dividend Growth(5Y)N/A

DPN/A

Div Incr Years0

Div Non Decr Years0

Ex-DateN/A

Surprises & Revisions

EPS beat(2)N/A

Avg EPS beat(2)N/A

Min EPS beat(2)N/A

Max EPS beat(2)N/A

EPS beat(4)N/A

Avg EPS beat(4)N/A

Min EPS beat(4)N/A

Max EPS beat(4)N/A

EPS beat(8)N/A

Avg EPS beat(8)N/A

EPS beat(12)N/A

Avg EPS beat(12)N/A

EPS beat(16)N/A

Avg EPS beat(16)N/A

Revenue beat(2)N/A

Avg Revenue beat(2)N/A

Min Revenue beat(2)N/A

Max Revenue beat(2)N/A

Revenue beat(4)N/A

Avg Revenue beat(4)N/A

Min Revenue beat(4)N/A

Max Revenue beat(4)N/A

Revenue beat(8)N/A

Avg Revenue beat(8)N/A

Revenue beat(12)N/A

Avg Revenue beat(12)N/A

Revenue beat(16)N/A

Avg Revenue beat(16)N/A

PT rev (1m)0%

PT rev (3m)0%

EPS NQ rev (1m)N/A

EPS NQ rev (3m)N/A

EPS NY rev (1m)0%

EPS NY rev (3m)0%

Revenue NQ rev (1m)N/A

Revenue NQ rev (3m)N/A

Revenue NY rev (1m)0%

Revenue NY rev (3m)0%

Valuation

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	0.03
P/S	0.8
P/FCF	N/A
P/OCF	N/A
P/B	0.16
P/tB	0.16
EV/EBITDA	N/A

EPS(TTM)-86.02

EYN/A

EPS(NY)232.39

Fwd EY3136.16%

FCF(TTM)-22.49

FCFYN/A

OCF(TTM)-21.47

OCFYN/A

SpS9.25

BVpS45.93

TBVpS45.93

PEG (NY)N/A

PEG (5Y)N/A

Graham NumberN/A

Profitability

		Industry Rank	Sector Rank
ROA	-61.34%
ROE	-91.95%
ROCE	N/A
ROIC	N/A
ROICexc	N/A
ROICexgc	N/A
OM	N/A
PM (TTM)	N/A
GM	N/A
FCFM	N/A

ROA(3y)-39.47%

ROA(5y)-35.64%

ROE(3y)-50.56%

ROE(5y)-45.74%

ROIC(3y)N/A

ROIC(5y)N/A

ROICexc(3y)N/A

ROICexc(5y)N/A

ROICexgc(3y)N/A

ROICexgc(5y)N/A

ROCE(3y)N/A

ROCE(5y)N/A

ROICexgc growth 3YN/A

ROICexgc growth 5YN/A

ROICexc growth 3YN/A

ROICexc growth 5YN/A

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3YN/A

GM growth 5YN/A

F-Score4

Asset Turnover0.13

Health

		Industry Rank	Sector Rank
Debt/Equity	0.4
Debt/FCF	N/A
Debt/EBITDA	N/A
Cap/Depr	26.74%
Cap/Sales	11.01%
Interest Coverage	N/A
Cash Conversion	N/A
Profit Quality	N/A
Current Ratio	2.1
Quick Ratio	1.74
Altman-Z	-4.2

F-Score4

WACC8.33%

ROIC/WACCN/A

Cap/Depr(3y)200.58%

Cap/Depr(5y)377.87%

Cap/Sales(3y)159.27%

Cap/Sales(5y)358.7%

Profit Quality(3y)N/A

Profit Quality(5y)N/A

High Growth Momentum

Growth

EPS 1Y (TTM)86.91%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%93.19%

EPS Next Y116.3%

EPS Next 2Y81.32%

EPS Next 3YN/A

EPS Next 5YN/A

Revenue 1Y (TTM)93.6%

Revenue growth 3Y10.64%

Revenue growth 5Y32.73%

Sales Q2Q%92.44%

Revenue Next Year70.85%

Revenue Next 2Y66.11%

Revenue Next 3Y11.1%

Revenue Next 5Y26.22%

EBIT growth 1Y14.19%

EBIT growth 3YN/A

EBIT growth 5YN/A

EBIT Next Year203.68%

EBIT Next 3Y53.88%

EBIT Next 5Y49.12%

FCF growth 1Y33.35%

FCF growth 3YN/A

FCF growth 5YN/A

OCF growth 1Y5.65%

OCF growth 3YN/A

OCF growth 5YN/A

ATLANTIC SAPPHIRE ASA / ASA.OL FAQ

What is the fundamental rating for ASA stock?

ChartMill assigns a fundamental rating of 3 / 10 to ASA.OL.

Can you provide the valuation status for ATLANTIC SAPPHIRE ASA?

ChartMill assigns a valuation rating of 4 / 10 to ATLANTIC SAPPHIRE ASA (ASA.OL). This can be considered as Fairly Valued.

What is the profitability of ASA stock?

ATLANTIC SAPPHIRE ASA (ASA.OL) has a profitability rating of 0 / 10.

How financially healthy is ATLANTIC SAPPHIRE ASA?

The financial health rating of ATLANTIC SAPPHIRE ASA (ASA.OL) is 3 / 10.

ATLANTIC SAPPHIRE ASA (ASA.OL) Stock Fundamental Analysis

1. Profitability

1.1 Basic Checks

1.2 Ratios

1.3 Margins

More info and screens

2. Health

2.1 Basic Checks

2.2 Solvency

2.3 Liquidity

More info and screens

3. Growth

3.1 Past

3.2 Future

3.3 Evolution

More info and screens

4. Valuation

4.1 Price/Earnings Ratio

4.2 Price Multiples

4.3 Compensation for Growth

More info and screens

5. Dividend

5.1 Amount

More info and screens

ATLANTIC SAPPHIRE ASA / ASA.OL FAQ

What is the fundamental rating for ASA stock?

Can you provide the valuation status for ATLANTIC SAPPHIRE ASA?

What is the profitability of ASA stock?

How financially healthy is ATLANTIC SAPPHIRE ASA?